How we treat bleeding associated with direct oral anticoagulants.

Giuseppe Marano, Stefania Vaglio, Simonetta Pupella, Giancarlo M Liumbruno, Massimo Franchini

Journal: Blood transfusion = Trasfusione del sangue 2017;14(5):465-73

PMID: 27136433

Abstract

Direct oral anticoagulants are at least as effective as vitamin K antagonists for the prevention and treatment of thromboembolism. Unfortunately, differently from vitamin K antagonists, they have the great drawback of lacking specific antidotes in the case of bleeding or emergency situations such as trauma, stroke requiring thrombolysis, and urgent surgery. The progressive development of antidotes for these new drugs, which, it is hoped, will become available in the near future, will allow better and safer management of the rapid reversal of their anticoagulant effect.

Address: Italian National Blood Centre, National Institute of Health, Rome, Italy.; Department of Transfusion Medicine and Haematology, "Carlo Poma" Hospital, Mantua, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.